DR. ASHLEY BAILEY OD
Prescription History 1760034821
Optometrist in Chehalis, WA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ASHLEY BAILEY OD, an active Optometrist specialist practicing in Chehalis, WA. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 567 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 118 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other WA PrescribersVs. WA Avg |
|---|---|---|---|
| Latanoprost | 118 | $27.11 | ≈ Typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 118 Medicare prescriptions for Latanoprost, about the same volume as the typical Washington prescriber of this medication (120). Medicare paid an average of $27.11 per fill, versus $24.23 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 186.8 30-Day Fills standardized to 30-day supplies 5,215 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 111 | $57.60 | ≈ Typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 111 Medicare prescriptions for Prednisolone Acetate, about 1.2 times the volume of the typical Washington prescriber of this medication (95). Medicare paid an average of $57.60 per fill, versus $48.29 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 129 30-Day Fills standardized to 30-day supplies 3,062 Days of Medication total across all patients in 2023 | |||
| Ketorolac Tromethamine | 74 | $27.52▼ below WA avg | ≈ Typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2023, this provider wrote 74 Medicare prescriptions for Ketorolac Tromethamine, about the same volume as the typical Washington prescriber of this medication (68). Medicare paid an average of $27.52 per fill, versus $28.29 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 79.2 30-Day Fills standardized to 30-day supplies 1,645 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 73 | $36.13 | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 73 Medicare prescriptions for Brimonidine Tartrate, about 1.4 times the volume of the typical Washington prescriber of this medication (54). Medicare paid an average of $36.13 per fill, versus $34.92 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 103.5 30-Day Fills standardized to 30-day supplies 2,810 Days of Medication total across all patients in 2023 | |||
| Ofloxacin | 61 | $23.70 | ≈ Typical |
About Ofloxacin: This medication is used to treat eye infections. Show more ▾ Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. In 2023, this provider wrote 61 Medicare prescriptions for Ofloxacin, about the same volume as the typical Washington prescriber of this medication (60). Medicare paid an average of $23.70 per fill, versus $18.95 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 66.3 30-Day Fills standardized to 30-day supplies 1,272 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 45 | $8.85▼ below WA avg | ▼ Less than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 45 Medicare prescriptions for Timolol Maleate, about 74% of the volume of the typical Washington prescriber of this medication (61). Medicare paid an average of $8.85 per fill, versus $22.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 80.1 30-Day Fills standardized to 30-day supplies 2,299 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 29 | $31.90▼ below WA avg | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 29 Medicare prescriptions for Dorzolamide Hcl, about 74% of the volume of the typical Washington prescriber of this medication (39). Medicare paid an average of $31.90 per fill, versus $31.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 47.1 30-Day Fills standardized to 30-day supplies 1,388 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 17 | $32.69▼ below WA avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 17 Medicare prescriptions for Dorzolamide-Timolol, about a quarter of the volume of the typical Washington prescriber of this medication (68). Medicare paid an average of $32.69 per fill, versus $33.25 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 30.5 30-Day Fills standardized to 30-day supplies 890 Days of Medication total across all patients in 2023 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 14 | $195.95▼ below WA avg | ▼ Less than typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2023, this provider wrote 14 Medicare prescriptions for Simbrinza, about half the volume of the typical Washington prescriber of this medication (25). Medicare paid an average of $195.95 per fill, versus $277.33 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 17.2 30-Day Fills standardized to 30-day supplies 502 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 13 | $95.17 | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 13 Medicare prescriptions for Dorzolamide-Timolol, about 19% of the volume of the typical Washington prescriber of this medication (68). Medicare paid an average of $95.17 per fill, versus $33.25 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 12 | $278.36▼ below WA avg | ▼ Less than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 12 Medicare prescriptions for Combigan, about half the volume of the typical Washington prescriber of this medication (28). Medicare paid an average of $278.36 per fill, versus $372.18 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 14 30-Day Fills standardized to 30-day supplies 400 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. ASHLEY BAILEY OD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Chehalis, WA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among WA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
